IUPAC NAME-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-8g-ergoline-8-carboxamide
or
1-[(6-Allylergolin-8β-yl)-carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
MOLECULAR FORMULA-C26H37N5O2
MOLAR MASS-451.604 g/mol
hyperprolactinemia
adjunctive therapy of prolactin-producing pituitary gland tumors (prolactinomas);
monotherapy of Parkinson's disease in the early phase;
combination therapy, together with levodopa and a decarboxylase inhibitor such as carbidopa, in progressive-phase Parkinson's disease;
SWAPNROOP DRUGS & PHARMACEUTICALS is a high tech enterprise which engaged in Loan Licensing Manufacturing of Pharmaceutical Formulation such as Tablets, Capsules, Liquid and semisolid Preparations and marketing of Quality Products in Domestic. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, cardiology, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. Also deals with trading o...
View more >>
Basic Information
Business Type: Manufacturer,Trading Company,Distributor/Wholesaler
Product/Service (We Buy): 11 - 50 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2000
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 97
Number of QC Staff: 11 - 20 People
Total Annual Sales Volume: US$1 Million - US$2.5 Million
India
China 
